baber/WOPTO huggingface dataset:
Patent AU-667046-B2 (AU)
Title: Collection device
Inventor: CATHCART BRUCE C
IPC: A61M1/00
Filed: 1992-06-10
Granted: 1996-03-07
Abstract: A collection device for receiving, collecting and returning blood from a body cavity, includes a housing for collecting the blood which has an inlet for fluid communication with the body cavity, a first outlet for returning blood to the body and a second outlet for coupling to a suction source. The collection device also includes a flow member which is configured and dimensioned so as to be disposed within the housing and so as to direct at least a portion of the blood entering through the inlet into a first predetermined direction and the remaining portion of the blood entering through the inlet and the first directed portion of blood in at least a second predetermined direction within the housing. The flow member can be a plate with ribs thereon to divert the flow of blood along the direction of the fibs. The collection device can also include a filter assembly positioned within the housing and about the plate so as to filter and defoam the blood before exiting from the housing.
Patent AU-725295-B2 (AU)
Title: Morphogen analogs and methods for producing them
Inventor: KECK PETER
IPC: G06F17/50
Filed: 1997-01-22
Granted: 2000-10-12
Abstract: The invention disclosed herein provides methods and compositions for the computer-assisted design of morphogen analogs. Practice of the invention is enabled by the use of at least a portion of the atomic co-ordinates defining the three-dimensional structure of human osteogenic protein-1 (hOP-1) as a starting point in the design of the morphogen analogs. In addition, the invention provides methods for producing morphogen analogs of interest, and methods for testing whether the resulting analogs mimic or agonize human OP-1-like biological activity. The invention also provides a family of morphogen analogs produced by such methods.
Patent AU-563500-B2 (AU)
Title: Variable pneumatic pressure mechanism
Inventor: JORGENSEN R B ACKERMAN R T
IPC: F15B15/10
Filed: 1983-11-04
Granted: 1987-07-09
Abstract: Attitude control mechanism for a flexible bag component of a composite pneumatic chamber including a fixed section over which an inturned portion of a flexible bag pneumatic chamber section rolls includes a cantilever bag attitude control stem having its root anchored in a mounting closing the end of the flexible bag remote from the rigid pneumatic chamber section and extends through a central guide aperture of at least one frame mounted within the rigid pneumatic chamber section for substantially linear reciprocation guidance so as to prevent appreciable buckling of the flexible bag as it is contracted axially by movement of the mounting carrying the stem toward the rigid pneumatic chamber section.
Patent AU-755591-B2 (AU)
Title: Deep-frozen creamy culinary product
Inventor: MOREAU JEAN
IPC: A23L23/00
Filed: 1999-04-06
Granted: 2002-12-19
Abstract: Frozen creamy culinary product with a water content of 60-85% comprises fat (4-12 wt.%), non dried pregelled starch (2-10 wt.%) and dried pregelled starch (2.5-4 wt.%). An Independent claim is also included for the production of a frozen creamy culinary product comprising: (1) mixing starch, fat and water to pregel and/or swell the starch; (2) adding the dried pregelled starch; (3) freezing the mixture continuously to -8 - -3 degrees C; and (4) cutting and/or shaping in pieces and/or portions, and deep-freezing them.
Patent AU-692548-B2 (AU)
Title: Corticotropin releasing factor antagonists
Inventor: CHEN YUHPYNG L
IPC: C07D213/69
Filed: 1995-06-06
Granted: 1998-06-11
Abstract: PCT No. PCT/IB95/00439 Sec. 371 Date Dec. 6, 1996 Sec. 102(e) Date Dec. 6, 1996 PCT Filed Jun. 6, 1995 PCT Pub. No. WO95/33750 PCT Pub. Date Dec. 14, 1995Corticotropin-releasing factor (CRF) antagonists having formulae (I), (II) or (III) wherein the dashed lines, A, B, Y, Z, G, R3, R4, R5, R6, R16 and R17 are as defined in the description, and processes for preparing them. These compounds and their pharmaceutically acceptable salts are useful in the treatment of CNS and stress-related disorders.
Patent AU-692736-B2 (AU)
Title: Use of N,N'-dibenzylethylenediamine-N,N'-diacetic acid derivatives as depigmenting agents
Inventor: GALEY JEAN-BAPTISTE
IPC: A61K8/92
Filed: 1997-06-16
Granted: 1998-06-11
Abstract: The use of a benzyl-ethylenediamine triacetic acid or dibenzyl-ethylenediamine diacetic acid of formula (I), or its salt, metal complex or ester, is claimed as a depigmenting and/or whitening agent in cosmetic compositions for human skin. X = COOH or 3-(Z1)-4-(Z2)-5-(Z5)-phenyl; Z1- Z3 = H or OR; R = optionally substituted, optionally unsaturated 1-8C alkyl. A corresponding skin depigmenting/whitening method is also claimed.
Patent AU-769408-B2 (AU)
Title: Broad spectrum decontamination formulation and method of use
Inventor: PURDON J GARFIELD
IPC: A62D101/22
Filed: 2000-02-15
Granted: 2004-01-29
Abstract: A decontamination formulation is provided which is effective against a broad spectrum of chemical and biological warfare agents and radioactive dusts, comprising an active decontamination agent, a co-solvent, a buffer system to optimize the initial reaction pH above 8.5 and more preferably in the range of 10 to 11 for favoring oxidation of VX and HD and hydrolysis of G agents, and a surfactant similar to fire-fighting foaming agent. Formulations comprise, in water by weight, 1% to 15% of a hydrated chloroisocyanuric acid salt, 1% to 10% of a polypropylene glycol co-solvent, 1% to 15% surfactant and a buffer system to initially maintain said formulation at a pH from about 11 to about 8.5 for sufficient duration to effect decontamination. The formulation can be provided in kit form or concentrate form, be prepared, in part, in advance or on site, and be dispensed in foam form which aids in coating and adhering of the decontamination formulation to contaminated surfaces. All ingredients can be pumped through a foam nozzle or water, co-solvent and surfactant can be pumped to the nozzle with solutions of buffer and of active ingredient being introduced at the nozzle for minimizing pump exposure.
Patent AU-737533-B2 (AU)
Title: Metered dose inhaler pump
Inventor: JEWETT WARREN R
IPC: B05B11/00
Filed: 1999-02-03
Granted: 2001-08-23
Abstract: A metered dose inhaler pump for delivering a metered dose of an active compound from an active compound inlet through a spray outlet without the need of a pressurized active compound container. Reciprocating action of an inlet valve, an outlet valve and a plunger alternately draw a metered dose of the active compound from an active compound container into an active compound chamber and pressurize the drawn metered dose of the active compound to eject the metered dose through the spray outlet. The plunger substantially fills and evacuates the metered dose chamber, leaving no void head space therein.
Patent AU-687227-B2 (AU)
Title: Method and apparatus for controlling power in a variable rate communication system
Inventor: TIEDEMANN EDWARD G JR
IPC: H04B7/26
Filed: 1995-07-05
Granted: 1998-02-19
Abstract: A method and apparatus for controlling transmission power in a variable rate communication system is disclosed. The method disclosed provides for a closed loop power control method. A first remote station controls the transmission power of a second remote station by transmitting a rate dependent power control signal to the second remote communication station. Since only the second communication knows its transmission rate a priori, it must determine its course of action in accordance with both the received power control signal and the knowledge of its transmission rate.
Patent AU-571265-B2 (AU)
Title: Oxopyrimidine derivatives
Inventor: LEVITT BARRIE
IPC: C07D239/00
Filed: 1984-09-10
Granted: 1988-04-14
Abstract: There are disclosed novel oxopyrimidine derivatives of the general formulawherein R, and R<sub>2</sub> may be the same or different and are each hydrogen or lowel alkyl optionally substituted by lower alkoxy, and R<sub>3</sub> and R<sub>4</sub> may be the same or different and are each phenyl optionally substituted by lower alkyl or halogen, with the proviso that when R, and R<sub>2</sub> are both hydrogen, R<sub>3</sub> and R<sub>4</sub> are each substituted phenyl. Pharmaceutical compositions containing these compounds are described. The compounds of the invention are active anticonvulsant, antianxiety and muscle relaxant agents.
Patent AU-618797-B2 (AU)
Title: Atomic absorption spectrometer
Inventor: DENCKS CARL GUNTHER
IPC: G01N21/72
Filed: 1989-03-13
Granted: 1992-01-09
Abstract: PCT No. PCT/EP89/00261 Sec. 371 Date Nov. 7, 1989 Sec. 102(e) Date Nov. 7, 1989 PCT Filed Mar. 13, 1989 PCT Pub. No. WO89/08833 PCT Pub. Date Sep. 21, 1989.An atomic absorption spectrometer with electrothermal atomization of the sample and background compensation by use of Zeeman effect comprises a furnace (130) for the electrothermal atomization of the sample which furnace is heated transverse to the direction of propagation of the measuring light beam (18) of the atomic absorption spectrometer and a switchable solenoid (44) for generating a magnetic field at the location of the sample which magnetic field extends parallel to the direction of propagation of the measuring light beam (18) such that the longitudinal Zeeman effect is obtained with switching on the solenoid (44). The solenoid (44) has pole pieces (46,48) with aligned apertures (50,52) for the passage of the measuring light beam (18). A contact carrier (96) is arranged on the pole pieces (48,50) in which contact carrier contacts (128,176) are supported in order to hold the transversely heated furnace (130), the axes of said contacts being perpendicular to the axis of the measuring light beam (18). Field coils (60,62) are arranged directly on the pole pieces (46,48). The contact carrier (96) forms an integral element with the coil holder (56,58).
Patent AU-779745-B2 (AU)
Title: Methods and reagents for treating glucose metabolic disorders
Inventor: PANG KEVIN
IPC: A61K45/00
Filed: 2000-02-10
Granted: 2005-02-10
Abstract: The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.
Patent AU-715295-B2 (AU)
Title: Use of GLP-1 or analogs in treatment of myocardial infarction
Inventor: EFENDIC SUAD
IPC: A61P9/10
Filed: 1997-08-26
Granted: 2000-01-20
Abstract: This invention provides a method of reducing mortality and morbidity after myocardial infarction. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.
Patent AU-774738-B2 (AU)
Title: (E)-styryl sulfone anticancer agents
Inventor: REDDY E PREMKUMAR
IPC: C08F28/02
Filed: 2000-03-31
Granted: 2004-07-08
Abstract: (E)-styryl benzylsulfones of formula (I) are useful as anticancer agents wherein R1, R2, R3, and R4 are independently selected from the group consisting of hydrogen, fluoro, chloro, iodo, bromo, C1-C6 alkyl, C1-C4 alkoxy, nitro, cyano and trifluoromethyl, with the proviso that (a) R1, R2, and R3 not all hydrogen when R4 is 2-chloro or 4-chloro; (b) when R1 and R3 are hydrogen and R2 is 4-bromo or 4-chloro, then R4 may not be 4-chloro, 4-fluoro or 4-bromo; (c) when R1 and R3 are hydrogen and R2 is 4-fluoro, then R4 may not be 4-fluoro or 4-bromo; (d) when R1 is hydrogen, and R4 is 2-fluoro, the R2 and R3 may not be 4-fluoro; and (e) when R1 is hydrogen and R3 is 4-hydrogen, 4-chloro, 4-bromo, 4-methyl or 4-methoxy, and R4 is 2-hydrogen, 2-chloro, or 2-fluoro; then R2 may not be 4-hydrogen, 4-chloro, 4-fluoro, or 4-bromo.
Patent AU-627516-B2 (AU)
Title: Applicator for administering mastitis treatment
Inventor: PYRET THOMAS W
IPC: A61D7/00
Filed: 1989-10-18
Granted: 1992-08-27
Abstract: An applicator for administering a veterinary pharmacological composition comprises a container having a cannula extending therefrom and a two-piece cap for releasably covering the cannula. The cap has an internal seal for sealing the cannula against leakage and contamination.
Patent AU-656479-B2 (AU)
Title: Method and standard solution for the determination of thyroxine (T4) or triiodothyronine (T3)
Inventor: LENZ HELMUT
IPC: G01N33/78
Filed: 1993-08-09
Granted: 1995-02-02
Abstract: In a process for determining thyroxine (T4) or triiodothyronine (T3) in serum, a standard solution which contains bovine thyroxine-binding globulin (TBG) and thyroxine or triiodothyronine dissolved in a buffer solution is used for calibration.
Patent AU-773495-B2 (AU)
Title: Spring cushioned shoe
Inventor: KRAFSUR DAVID S
IPC: A43B13/18
Filed: 2000-04-26
Granted: 2004-05-27
Abstract: A spring cushioned shoe is disclosed. The shoe includes a sole assembly that has a first spring disposed within a vacuity in the heel portion of the assembly, and a second spring disposed within a vacuity in the ball portion of the assembly. The springs are, e.g., wave springs that extend vertically from the upper to the lower internal boundaries of the vacuities.
Patent AU-628901-B2 (AU)
Title: Bi-level card edge connector and method of making same
Inventor: EISENBERG DONALD S
IPC: H01R12/72
Filed: 1989-12-20
Granted: 1992-09-24
Abstract: A bi-level connector for making mechanical and electrical contact between a mother printed circuit board and a daughter printed circuit board. The connector comprises lower level contacts with a varied spring rate when a daughter printed circuit board is inserted. The method of manufacturing the connector comprises forming a strip of two types of contacts, upper contacts and lower contacts, on a single carry strip in alternating fashion such that both the upper and lower contacts can be simultaneously inserted into a connector housing in a single insertion process.
Patent AU-676499-B2 (AU)
Title: Fuel compositions containing organic molybdenum complexes
Inventor: KAROL THOMAS J
IPC: C10L1/30
Filed: 1996-04-03
Granted: 1997-03-13
Abstract: Oxidative stability of petroleum motor fuel is improved by adding to the fuel an effective amount of heterocyclic molybdenum complex prepared by reacting (a) diol, amino or amino-alcohol compound and (b) a molybdenum source sufficient to yield about 2.0 to 20.0 percent of molybdenum based on the weight of the complex.
Patent AU-766230-B2 (AU)
Title: Aminotetralin derivative for the therapy of cardiovascular diseases
Inventor: BONGRANI STEFANO
IPC: A61K45/00
Filed: 2000-06-07
Granted: 2003-10-09
Abstract: The invention relates to a method of treatment of left ventricular dysfunction, by administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof.
Patent AU-741799-B2 (AU)
Title: Method and packaging utilizing calcium cyanamide for soil treatment
Inventor: HARTMAN RICHARD O W
IPC: C05C7/00
Filed: 1997-10-20
Granted: 2001-12-13
Abstract: Processes and structures for using calcium cyanamide fertilizer in a manner to greatly enhance its most effective soil treatment form prior to its application. Calcium cyanamide transformation structures have both fertilizing and pesticidal qualities; however, it is difficult to obtain uniform, efficient effectiveness from dry calcium cyanamide's liquid transformation structures. In the process of this invention, dry, dusty granules and fines of calcium cyanamide are placed directly into tanks of liquid for transformation or within biodegradable bags through which water can freely flow. The bags are submerged in a tank of water. The insoluble calcium and carbon components thereof remain as solid residuals within the bags. Hydrolysis occurs and the solution is biocidal and ready for immediate application. The solution can be sprayed or irrigated onto a targeted soil area with conventional dispersal equipment. The remaining non-dissolved material in the bags can be dispersed on and into the plant crop soil. Additives of other fertilizers into the above solution can be used to enhance effectiveness. When the calcium cyanamide is placed directly into the liquid, the mixture will become slurry-like. In the processes herein, when the solids of calcium cyanamide are not isolated during hydrolysis, the slurry mixture is utilized in recent modern specialized solids fertilizer suspension dispersed equipment having sufficient agitation to keep the solids in suspension.
Patent AU-663425-B2 (AU)
Title: Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
Inventor: WEICHERT ANDREAS
IPC: A61K31/155
Filed: 1993-12-13
Granted: 1995-10-05
Abstract: Benzoylguanidines of the formula I <IMAGE>     where R(1) is hydrogen, Hal, -NO2, -CN, -CF3, R(4)-SOm or R(5)R(6)N-SO2-, where m is zero to 2, R(4) and R(5) are alk(en)yl or -CnH2n-R(7), n is zero to 4, with R(5) also having the meaning of H, and R(6) is H or (C1-C4)-alkyl, with R(5) and R(6) together being able to be 4 or 5 methylene groups,   R(2) is -SR(10), -OR(10), -NHR(10), -NR(10)R(11), -CHR(10)R(12), <IMAGE>     with R(10) and R(11) being identical or different and being -[CHR(16)]s-(CH2)p-(CHOH)q-(CH2)r-(CH2OH)t-R(21) or -(CH2)p-O(CH2-CH2O)q-R(21), R(12) and R(13) being hydrogen or alkyl, or forming a cycloalkyl together with the carbon atom carrying them,   R(14) being H, (cyclo)alkyl or -CnH2n-R(15),   R(3) is defined as R(1) or is alkyl, hydrogen or -X-R(22), where X is oxygen, S or NR(16),  are described, as are the pharmaceutically tolerated salts thereof. The compounds I possess very good anti-arrhythmic properties but do not have any undesirable salidiuretic properties. In addition to this, they are notable for their strong inhibitory effect on the proliferation of cells.
Patent AU-585580-B2 (AU)
Title: Method and apparatus for increasing the turbulence in a gas exposed to low frequency sound
Inventor: OLSSON MATS ANDERS
IPC: B01D53/60
Filed: 1986-01-22
Granted: 1989-06-22
Abstract: PCT No. PCT/SE86/00019 Sec. 371 Date Oct. 3, 1986 Sec. 102(e) Date Oct. 3, 1986 PCT Filed Jan. 22, 1986 PCT Pub. No. WO86/04263 PCT Pub. Date Jul. 31, 1986.Method and apparatus for increasing the turbulence in a gas exposed to low frequency sound. The gas is exposed to sound produced by a sound generator (10) which has a tubular resonator (11) having an open end and is operated at one of the resonance frequencies of the resonator having a maximum frequency of 150 Hz. The gas is flown into the tubular resonator through the open end thereof and is discharged from the resonator substantially in a region, where the sound pressure of the standing wave in the resonator has a node, after having passed through a substantial length of the resonator.
Patent AU-726510-B2 (AU)
Title: Pharmaceutical compositions and devices for their administration
Inventor: MCCARTHY PAUL
IPC: B65D83/44
Filed: 1997-12-04
Granted: 2000-11-09
Abstract: A device for providing pharmaceutical doses comprising a container, filled with a pharmaceutical composition including a pharmaceutically active agent in a solution of liquified 1,1,1,2-tetrafluoroethane (HFC-134a), or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227) and a carrier. The carrier can be a pharmaceutically acceptable alcohol, polyol, (poly)alkoxy derivative, fatty acid alkyl ester, polyalkylene glycol, or dimethyl sulphoxide. The device includes valve means arranged for delivering aerosol doses of said pharmaceutical composition to the exterior of the container, and at least a portion of the device is formed from a polyester.
Patent AU-638988-B2 (AU)
Title: Floor grid system
IPC: E04B5/02
Filed: 1990-05-03
Granted: 1993-07-15
Abstract: The floor assembly (10) for a building structure, comprises a plurality of support members defining a horizontal perimeter supported by the building structure, said support member including a containment ring (50) formed from a plurality of coplanar containment members (12) joined at the ends thereof to form a unitary body; a grid formed of a plurality of horizontal grid members (24,26) extending between said support members; pocket surfaces (82,84) on adjoining ones of said grid members (24,25) defining pockets (180); and a glass block (28) fitted into each pocket, to form a floor assembly (10) wherein said glass blocks (28) define a horizontal glass floor surface supported by said grid members (24,25), with said grid members (24, 26) being supported by said support member.
Patent AU-591115-B2 (AU)
Title: Programming device for a stored-program controller
Inventor: KAUFMANN FELIX
IPC: G05B19/04
Filed: 1986-04-23
Granted: 1989-11-30
Abstract: The present invention relates to a programming device for a stored-program controller, in which the control program of the controller, containing function calls and stored in a machine-readable form, is displayed in function-diagram representation on a graphical display device by the operating system of a digital computer contained in the programming device. The invention proposes operations in the operating system of the digital computer by means of which the prerequisites are created for the automatic generation of function-diagram representations in which signal branchings and signal intersections are permissible and which, therefore, have a considerably higher information content than the purely hierarchically structured function-diagram representations hitherto generated.
Patent AU-778293-B2 (AU)
Title: At least partially implantable hearing system for rehabilitation of a hearing disorder
Inventor: STOCKERT FRIEDEMANN
IPC: H04R17/00
Filed: 2001-08-10
Granted: 2004-11-25
Abstract: The system has a switchable coupling arrangement that EPcouples a passive coupling element from a transducer output when the driving electronics is inactive so that the mechanical output impedance of the transducer has essentially no effect on the natural resonance of the bone chain in the middle ear and hence the natural residual hearing capacity for sound in air is substantially maintained. The system has at least one sound detection sensor for picking up sound signals and converting them to electrical form, an electronic signal processing unit, a power stage and at least one active electromechanical element (12,13) of an electromechanical transducer (10) for stimulating a small middle ear bone via a passive coupling element (21). A switchable coupling arrangement (22) decouples the passive element from the transducer output when the driving electronics is inactive so that the mechanical output impedance of the transducer has essentially no effect on the natural resonance of the bone chain in the middle ear and hence the natural residual hearing capacity of for sound in air is substantially maintained. Independent claims are also included for the following: an arrangement for implementing the method.
Patent AU-670682-B2 (AU)
Title: Pressurized screen arrangement
Inventor: LARSSON PAR-ERIK
IPC: D21D5/02
Filed: 1994-01-12
Granted: 1996-07-25
Abstract: PCT No. PCT/SE94/00013 Sec. 371 Date Aug. 7, 1995 Sec. 102(e) Date Aug. 7, 1995 PCT Filed Jan. 12, 1994 PCT Pub. No. WO94/18387 PCT Pub. Date Aug. 18, 1994A pressurized screen arrangement for screening lignocellulose containing fiber material, comprising a screen housing (10) with a screen cage (11) are arranged in first and, respectively, second attachment members (17, 18) in the screen housing. Both ends of the screen cage (11) are fitted into the attachment members (17,18) with radial clearance, and an axial support (21) is provided at least at one of the attachment members (17,18).